About 100 reports

  • EXELON

The patch formulation causes lesser gastrointestinal tract-related side effects (such as nausea and vomiting) than the Exelon capsule.

  • Dementia
  • Forecast
  • Allergan plc
  • Eisai Co., Ltd.
  • Novartis AG

This method avoids the gastrointestinal tract and leads to more rapid effects, compared to orally administered levodopa.

  • Dementia
  • World
  • Biogen Idec Inc.
  • Novartis AG
  • Roche Group
  • 7.2.2 EXELON (RIVASTIGMINE, RIVASTIGMINE TARTRATE)
  • 12.2 ABBREVIATIONS

Ibuprofen is associated with adverse effects such as gastrointestinal effects and irritation.

  • Dementia
  • Allergan plc
  • Biogen Idec Inc.
  • Eisai Co., Ltd.
  • Novartis AG

Their research is focused on areas of expertise in neurology and gastrointestinal diseases, as Theyll as oncology.

  • Dementia
  • China
  • Demand
  • Guizhou Yibai Pharmaceutical Co., Ltd.
  • Kunming Longjin Pharmaceutical Co Ltd

AD is one of the most common types of NDDs.

  • Dementia
  • Eli Lilly & Co.
  • F. Hoffmann-La Roche Ltd.
  • Johnson & Johnson
  • Merck & Co., Inc.

Their research is focused on areas of expertise in neurology and gastrointestinal diseases, as Theyll as oncology.

  • Dementia
  • China
  • Guizhou Xinbang Pharmaceutical Company Limited
  • Guizhou Yibai Pharmaceutical Co., Ltd.
  • Kunming Longjin Pharmaceutical Co Ltd

Drivers and their Impact Impact on Key Customer Segments Driver Unmet Medical Needs Increase in Patient Population Low Low ## ## ## ## ## High High Hospitals ## ## ## ## ## Promising Drug Pipeline Special Provision for Rare Diseases Low Low ## ## ## ## ## High High ## ## ## ## ##

  • Dementia
  • Biogen Idec Inc.
  • Merck Serono S.A.
  • Novartis AG
  • Pfizer Inc.
  • 9.3 BIBLIOGRAPHY
  • 9 Appendix

The studies indicated in the heat map show that galantamine and rivastigmine both have higher incidences of Gastrointestinal (GI) side effects than donepezil.

  • Dementia
  • East Asia
  • World
  • Forecast
  • Biogen Idec Inc.
  • 10.1 All Pipeline Drugs by Phase

The studies indicated in the heat map show that galantamine and rivastigmine both have higher incidences of Gastrointestinal (GI) side effects than donepezil.

  • Dementia
  • World
  • Forecast
  • Market Size
  • Eisai Co., Ltd.

Gastrointestinal and Respiratory drugs were the other major segments with ##% and ##% share respectively.

  • Dementia
  • Eli Lilly & Co.
  • Novartis AG
  • Pfizer Inc.
  • Roche Group

Medication is often lifelong, and long-standing treatment can eventually lead to complications such as osteoporosis, pneumonia and gastrointestinal infection.

  • Cancer
  • Dementia
  • Sweden
  • Karolinska Institutet Holding
  • Takeda Pharmaceutical Company Limited

ALZHEIMER' S & DEMENTIA; ##(##): ##-##.

  • Dementia
  • Market Size
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Roche Group

Alzheimer's disease

4546 5000 3864
  • WHILE CURRENT PHARMACOTHERAPIES ARE CONSIDERED TOLERABLE, THERE IS ALWAYS ROOM FOR IMPROVEMENT
  • Product profile (late stage): encenicline

BIBLIOGRAPHY Alzheimer' s disease Disease Coverage | Forecast: Alzheimer' s Disease DMKC## US ##, ## ## ## ## ## ## ## ## ## ## -##. ## Japan ## ## ## ## ## ## ## ## ## ## -##. ## France ## ## ## ## ## ## ## ## ## ## -##. ## German

  • Dementia
  • East Asia
  • European Union
  • Japan
  • United States
  • PLANT EXTRACTS AND COMPOUNDS HAVE BEEN EXTENSIVELY REVIEWED

SUCH CHEMICALS ARE NO DOUBT BIOSYNTHESIZED TO DETER PREDATORS, AND IF INGESTED CAUSE SEVERE GASTROINTESTINAL EFFECTS.

  • Dementia
  • United States
  • World
  • Cowen & Co., LLC
  • Pfizer Inc.
  • Amyotrophic Lateral Sclerosis
  • MASITINIB - DRUG PROFILE

One patient had a Sprycel-related AE leading to discontinuation, and one patient died from gastrointestinal bleeding unrelated to treatment.

  • Dementia
  • Therapy
  • United States
  • Product Initiative
  • AB Science SA
  • GBIHC414MR / Published SEP 2016 Page 184

Symptoms usually include gastrointestinal issues such as diarrhea and vomiting, alongside other issues such as nausea and headaches.

  • Dementia
  • World
  • Company
  • Company Financials
  • Forecast
  • variability, compared to the parent molecule, tramiprosate.
  • variability, compared to the parent molecule, tramiprosate.

Down Syndrome - Overview Down Syndrome - Therapeutics Development NUMBER OF PRODUCTS UNDER DEVELOPMENT FOR DOWN SYNDROME, H## 2018 PIPELINE OVERVIEW NUMBER OF PRODUCTS UNDER DEVELOPMENT FOR DOWN SYNDROME, H## 2018 Phase I ## ## Preclinical ## ## Discovery ## ## Unknown ## ## Total ## ## NUMBER OF PROD

  • Dementia
  • Therapy
  • United States
  • World
  • Product Initiative

SR One Ltd.

  • Dementia
  • Pharmaceutical
  • Psychotic Disorder
  • United States
  • Janssen Biotech, Inc.

The molecules developed by companies in Phase I, Phase ##, Preclinical and Discovery stages are ##, ##, ## and ## respectively.

  • Dementia
  • United States
  • World
  • Product Initiative
  • Virobay Inc.

It acts by targeting ## beta hydroxysteroid dehydrogenase ## (##beta-HSD-##).

  • Dementia
  • United Kingdom
  • World
  • Product Initiative
  • Actinogen Limited

The company reported one pharmaceuticals & healthcare deal each in 2016 and 2017.

  • Dementia
  • United Kingdom
  • Company
  • M&A
  • IXICO plc

Each security is composed of one ordinary share and one warrant.

  • Antimalarials
  • Dementia
  • Healthcare
  • Therapy
  • AB Science SA

It offers the treatment of diseases related to gastrointestinal tract, gastric and hepatic conditions, critical and supportive care.

  • Dementia
  • Therapy
  • United States
  • Company
  • Abeona Therapeutics, Inc.

Patients with DRE met zero or one major criteria and one to two minor criteria.

  • Dementia
  • Pharmaceutical
  • Therapy
  • United States
  • Lundbeck Inc.
  • SMALL MOLECULE TO ACTIVATE SOD-1 FOR AMYOTROPHIC LATERAL SCLEROSIS AND PARKINSON'S DISEASE - DRUG PROFILE

THN-## is an inhibitor of superoxide dismutase-## (SOD-##).

  • Dementia
  • Turkey
  • United States
  • World
  • Product Initiative
  • MASITINIB - DRUG PROFILE

One of the important non-motor features of Parkinson s disease is often the early presentation of severe and disabling impairment of gastrointestinal function.

  • Dementia
  • Neurological Disorder
  • United States
  • Product Initiative
  • AB Science SA
  • Aug 31, 2017: Probiodrug reports financial results for H1 2017 and corporate update
  • Nov 30, 2017: Probiodrug reports Third Quarter 2017 Business Update

They have a remaining term of up to one year.

  • Dementia
  • Healthcare
  • Pharmaceutical
  • United States
  • Probiodrug AG

It acts by targeting ## beta hydroxysteroid dehydrogenase ## (##beta-HSD-##).

  • Dementia
  • Hormone
  • United Kingdom
  • Product Initiative
  • Actinogen Limited

One patient in the low-dose cohort had a ##x## gc/ kg.

  • Blood Disease
  • Dementia
  • United States
  • Company
  • uniQure N.V.
  • PIPELINE BY LES LABORATOIRES SERVIER SAS, H1 2018
  • PIPELINE BY ONO PHARMACEUTICAL CO LTD, H1 2018

The company' s portfolio of marketed products treat central nervous system disorders, cardiovascular diseases, cancer, ENT disorders, respiratory diseases, women' s health issues, gastrointestinal diseases, hematological disorders, hormonal disorders and others.

  • Dementia
  • Mental Health
  • Therapy
  • World
  • Product Initiative